BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27510982)

  • 1. Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats.
    Liu Y; Luo X; Yang C; Yang T; Zhou J; Shi S
    Mol Med Rep; 2016 Oct; 14(4):3073-85. PubMed ID: 27510982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin‑3‑O‑β‑D‑glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats.
    Yang T; Liu Y; Huang X; Zhang R; Yang C; Zhou J; Zhang Y; Wan J; Shi S
    Mol Med Rep; 2018 Sep; 18(3):2599-2612. PubMed ID: 30015887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats.
    Kawase A; Ito A; Yamada A; Iwaki M
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):239-44. PubMed ID: 24899460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
    Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
    J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
    Ikemura K; Inoue K; Mizutani H; Oka H; Iwamoto T; Okuda M
    Eur J Pharmacol; 2012 Sep; 690(1-3):192-201. PubMed ID: 22749977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Long-Lasting Oatp Inhibition by Typical Inhibitor Cyclosporine A and In Vitro-In Vivo Discrepancy in Its Drug Interaction Potential in Rats.
    Taguchi T; Masuo Y; Kogi T; Nakamichi N; Kato Y
    J Pharm Sci; 2016 Jul; 105(7):2231-9. PubMed ID: 27290622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
    Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
    J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-associated differences in transporter gene expression in kidneys of male rats.
    Xu YJ; Wang Y; Lu YF; Xu SF; Wu Q; Liu J
    Mol Med Rep; 2017 Jan; 15(1):474-482. PubMed ID: 27909713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Transporter-Mediated Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin.
    Wang Q; Zheng M; Leil T
    CPT Pharmacometrics Syst Pharmacol; 2017 Apr; 6(4):228-238. PubMed ID: 28296193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
    Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
    Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats.
    Kageyama M; Namiki H; Fukushima H; Ito Y; Shibata N; Takada K
    Biol Pharm Bull; 2005 Feb; 28(2):316-22. PubMed ID: 15684491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in broiler chickens.
    Patel HB; Patel UD; Mathapati BS; Modi CM
    Res Vet Sci; 2019 Oct; 126():178-183. PubMed ID: 31539794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for pharmacokinetic interactions between ambrisentan and cyclosporine.
    Spence R; Mandagere A; Richards DB; Magee MH; Dufton C; Boinpally R
    Clin Pharmacol Ther; 2010 Oct; 88(4):513-20. PubMed ID: 20811346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.
    Ieiri I; Higuchi S; Sugiyama Y
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver.
    Hagenbuch N; Reichel C; Stieger B; Cattori V; Fattinger KE; Landmann L; Meier PJ; Kullak-Ublick GA
    J Hepatol; 2001 Jun; 34(6):881-7. PubMed ID: 11451172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smilax glabra Rhizoma affects the pharmacokinetics and tissue distribution of methotrexate by increasing the P‑glycoprotein mRNA expression in rats after oral administration.
    Li Y; Deng S; Ζhao Y; Liu L; Zhao R
    Mol Med Rep; 2017 Nov; 16(5):7633-7640. PubMed ID: 28944899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic interaction between cyclosporine and sirolimus.
    Bai S; Stepkowski SM; Kahan BD; Brunner LJ
    Transplantation; 2004 May; 77(10):1507-12. PubMed ID: 15239612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine markedly raises the plasma concentrations of repaglinide.
    Kajosaari LI; Niemi M; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2005 Oct; 78(4):388-99. PubMed ID: 16198658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.